Abraham Scaria

Company: Beacon Therapeutics

Job title: Chief Scientific Officer

Seminars:

Panel Discussion: Comparing Gene Therapy Approaches for Wet AMD: Delivery Methods, Targets, & Therapeutic Potential 3:00 pm

How are intravitreal and subretinal delivery methods impacting treatment precision, effectiveness, and patient experience? What are the implications of targeting VEGF suppression versus complement modulation on efficacy and safety? How can we optimize long-term outcomes by addressing durability, immune response, and safety across different gene therapy approaches?Read more

day: Day Two